1.
Dhingra S, Sachdeva M. Expanding horizons in the treatment of mantle cell lymphoma: Ibrutinib a novel BTK-targeting inhibitor. Int J Basic Clin Pharmacol [Internet]. 2017 Jan. 23 [cited 2024 Mar. 29];3(1):249-54. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/991